Apostolos Zaravinos

5.7k total citations
128 papers, 3.8k citations indexed

About

Apostolos Zaravinos is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Apostolos Zaravinos has authored 128 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Molecular Biology, 39 papers in Oncology and 28 papers in Cancer Research. Recurrent topics in Apostolos Zaravinos's work include Cancer Immunotherapy and Biomarkers (21 papers), Bladder and Urothelial Cancer Treatments (12 papers) and RNA modifications and cancer (11 papers). Apostolos Zaravinos is often cited by papers focused on Cancer Immunotherapy and Biomarkers (21 papers), Bladder and Urothelial Cancer Treatments (12 papers) and RNA modifications and cancer (11 papers). Apostolos Zaravinos collaborates with scholars based in Greece, Cyprus and United States. Apostolos Zaravinos's co-authors include Demetrios�� Spandidos, Dionysios V. Chartoumpekis, Venetsana Kyriazopoulou, George Ι. Lambrou, Ilias Georgakopoulos‐Soares, Theodoulakis Christofi, Stavroula Baritaki, Jelena Radojicic, Maria Koutsaki and Dimitris Delakas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and SHILAP Revista de lepidopterología.

In The Last Decade

Apostolos Zaravinos

123 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Apostolos Zaravinos Greece 34 2.1k 1.4k 992 450 450 128 3.8k
Hannes Hentze Singapore 24 2.4k 1.1× 1.4k 1.0× 954 1.0× 544 1.2× 372 0.8× 37 4.1k
Kenjiro Sawada Japan 40 2.7k 1.3× 1.5k 1.0× 1.3k 1.3× 409 0.9× 1.0k 2.2× 137 5.0k
Joanna H. Tong Hong Kong 37 2.3k 1.1× 1.3k 1.0× 1.3k 1.3× 1.0k 2.3× 354 0.8× 62 4.4k
Atsushi Kaneda Japan 38 3.1k 1.5× 986 0.7× 1.2k 1.2× 542 1.2× 534 1.2× 129 4.8k
Trivadi S. Ganesan India 32 1.7k 0.8× 590 0.4× 1.2k 1.2× 365 0.8× 529 1.2× 166 3.8k
Seiji Mabuchi Japan 42 2.4k 1.1× 1.1k 0.8× 1.6k 1.6× 509 1.1× 959 2.1× 192 5.7k
Rouba Ali‐Fehmi United States 39 1.2k 0.5× 874 0.6× 811 0.8× 464 1.0× 416 0.9× 152 4.2k
Hidetaka Katabuchi Japan 41 1.4k 0.7× 743 0.5× 1.1k 1.1× 371 0.8× 1.0k 2.3× 191 5.1k
US Khoo Hong Kong 33 2.0k 1.0× 688 0.5× 840 0.8× 319 0.7× 329 0.7× 131 3.7k
Paul Haluska United States 38 2.5k 1.2× 1.1k 0.8× 2.0k 2.0× 618 1.4× 497 1.1× 114 4.9k

Countries citing papers authored by Apostolos Zaravinos

Since Specialization
Citations

This map shows the geographic impact of Apostolos Zaravinos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Apostolos Zaravinos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Apostolos Zaravinos more than expected).

Fields of papers citing papers by Apostolos Zaravinos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Apostolos Zaravinos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Apostolos Zaravinos. The network helps show where Apostolos Zaravinos may publish in the future.

Co-authorship network of co-authors of Apostolos Zaravinos

This figure shows the co-authorship network connecting the top 25 collaborators of Apostolos Zaravinos. A scholar is included among the top collaborators of Apostolos Zaravinos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Apostolos Zaravinos. Apostolos Zaravinos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zaravinos, Apostolos, et al.. (2025). Characterization of Exhausted T Cell Signatures in Pan-Cancer Settings. International Journal of Molecular Sciences. 26(5). 2311–2311. 1 indexed citations
2.
Nayak, Akshatha, Fotis A. Baltoumas, Wilfried M. Guiblet, et al.. (2025). Quadrupia provides a comprehensive catalog of G-quadruplexes across genomes from the tree of life. Genome Research. 35(11). 2578–2600.
3.
Zaravinos, Apostolos, et al.. (2024). Therapeutic Implications of Targeting YY1 in Glioblastoma. Cancers. 16(11). 2074–2074. 6 indexed citations
5.
6.
Kourti, Malamati, et al.. (2023). Signatures of Co-Deregulated Genes and Their Transcriptional Regulators in Kidney Cancers. International Journal of Molecular Sciences. 24(7). 6577–6577. 2 indexed citations
7.
Zaravinos, Apostolos, et al.. (2022). Genomic landscape of the immunogenicity regulation in skin melanomas with diverse tumor mutation burden. Frontiers in Immunology. 13. 1006665–1006665. 8 indexed citations
8.
Georgakopoulos‐Soares, Ilias, et al.. (2021). Distinct genomic features across cytolytic subgroups in skin melanoma. Cancer Immunology Immunotherapy. 70(11). 3137–3154. 15 indexed citations
9.
Lambrou, George Ι., et al.. (2021). Dual Mechanisms of Metabolism and Gene Expression of the CCRF-CEM Leukemia Cells under Glucocorticoid Treatment. International Journal of Molecular Sciences. 22(11). 5889–5889. 1 indexed citations
10.
Zaravinos, Apostolos, et al.. (2021). Defective Natural Killer Cells in Melanoma: Role of NKG2D in Pathogenesis and Immunotherapy. Critical Reviews in Immunology. 41(2). 45–76. 6 indexed citations
11.
Zaravinos, Apostolos, et al.. (2020). Human papillomavirus E7 binds Oct4 and regulates its activity in HPV-associated cervical cancers. PLoS Pathogens. 16(4). e1008468–e1008468. 17 indexed citations
12.
13.
Chinello, Clizia, Isabella Piga, Andrew Smith, et al.. (2018). Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma. Journal of Proteomics. 191(4). 29–37. 23 indexed citations
14.
Zaravinos, Apostolos. (2017). Oncogenic RAS: From Its Activation to Its Direct Targeting. Critical Reviews™ in Oncogenesis. 22(3-4). 283–301. 1 indexed citations
15.
Ayiomamitis, Georgios, et al.. (2014). Differences in telomerase activity between colon and rectal cancer. Canadian Journal of Surgery. 57(3). 199–208. 21 indexed citations
16.
Ayiomamitis, Georgios, George Notas, Apostolos Zaravinos, Μαρία Γεωργιάδου, & Elias Kouroumalis. (2011). Differences in telomerase activity between colon and rectal cancer. Gut. 60(Suppl 1). A71.1–A71. 1 indexed citations
17.
Zaravinos, Apostolos, et al.. (2011). UP-01.018 Linear Correlations in Chromosomal-Based Gene Expression in Urinary Bladder Cancer. Urology. 78(3). S190–S190. 1 indexed citations
18.
Zaravinos, Apostolos, et al.. (2010). Implication of RAF and RKIP Genes in Urinary Bladder Cancer. Pathology & Oncology Research. 17(2). 181–190. 31 indexed citations
19.
Volanis, Dimitrios, Apostolos Zaravinos, Tanya Kadiyska, et al.. (2010). Expression analysis of the Rho kinases in urinary bladder cancer. International Journal of Molecular Medicine. 26. 1 indexed citations
20.
Zaravinos, Apostolos, John G. Bizakis, & Demetrios�� Spandidos. (2009). Prevalence of human papilloma virus and human herpes virus types 1–7 in human nasal polyposis. Journal of Medical Virology. 81(9). 1613–1619. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026